David Tinklepaugh, MD
Neuromuscular Medicine · Mystic, CTNPI 1982711586
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.6% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations.
Across 71 payments — averaging $24.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$359
- CSL Behring$304
- Sunovion Pharmaceuticals Inc.$197
- Novartis$190
- EMD Serono, Inc.$139
- AstraZeneca$133
- plus $431 from 15 others
What the payments were for
- Food & beverage$1,58891%
- Education$1659%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 14 | $359 |
| CSL Behring | 5 | $304 |
| Sunovion Pharmaceuticals Inc. | 16 | $197 |
| Novartis | 14 | $190 |
| EMD Serono, Inc. | 2 | $139 |
| AstraZeneca(2 entities) | 3 | $133 |
| Boston Scientific | 1 | $97 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Averitas Pharma Inc. | 1 | $34 |
| UCB, Inc. | 1 | $29 |
| Grifols USA, LLC | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| Catalyst Pharmaceuticals, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Mallinckrodt Enterprises LLC | 1 | $19 |
| Amgen | 1 | $19 |
| Biogen | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hizentra$110
How this compares
Too few neuromuscular medicine providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 101 | $1,248,220 |
| VyvgartEfgartigimod Alfa-Fcab | 18 | $1,121,846 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 13 | $487,530 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 30 | $383,189 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 25 | $250,874 |
| Gabapentin | 234 | $3,867 |
| Pyridostigmine Bromide | 32 | $1,915 |
| Pregabalin | 53 | $1,902 |
| Duloxetine Hcl | 53 | $1,312 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 33 | $424 |
| Azathioprine | 11 | $223 |
| Prednisone | 17 | $149 |
| Nortriptyline Hcl | 11 | $140 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Grifols USA, LLCGamunex-C | $29 | $1,248,220101 claims |
| CSL BehringHizentra, Privigen | $304 | $870,71943 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $22 | $1,91532 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few neuromuscular medicine providers in Connecticuton file to place this against a meaningful peer group, so we don't.
Other neuromuscular medicine in Mystic
- John TauroNorwich$54K
- Sasa ZivkovicGuilford$37K
- Bhaskar RoyNew Haven$17K
- Barry GordonMeriden$3K
- Kevin FeliceNew Britain$2K
- Ylec Cardenas CastilloNew Haven$1K
- Arpad FejosMiddletown$1K
- Bilal HameedNew London$1K
- Zara KhanWestport$1K
- Idaira Aguilar TejedorStratford$864
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.